VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1387624
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: She's developed an itchy rash, like dermatitis, "on my upper arms and from my kneecaps down to my ankle; She's developed an itchy rash, like dermatitis, "on my upper arms and from my kneecaps down to my ankle; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date not reported), via an unspecified route of administration on an unspecified date (at an unspecified age) at 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took paracetamol (TYLENOL) for small rash that didn't itch, feeling tired, and headache. Historical vaccine included first dose of BNT162B2 received on an unspecified date for COVID-19 immunization, where the patient experienced small rash that didn't itch, feeling tired, and headache. The patient treated her symptoms by taking 2 paracetamol (TYLENOL), and symptoms resolved. The patient reported of receiving both doses of Pfizer COVID-19 vaccine. But after the second dose, the patient developed an itchy rash, like dermatitis, on the patient's upper arms and from her kneecaps down to her ankle. The patient received a steroid cream as a treatment for the events. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387625
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: nausea; vomit; fatigue; This is a spontaneous case received from a contactable consumer (patient). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported that she experienced side effects 5 days after the administration of the second dose of the Pfizer's COVID-19 vaccine, she started with nausea and vomit for 24 hours and fatigue for several days. It was reported that now she feels fine. The outcome of events was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387626
Sex: M
Age:
State: OK

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: he had a little bit of a funny taste which tasted like metal; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program COVAX US Support. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient was concerned about the minor reaction that he experienced with the first dose of the Pfizer COVID-19 vaccine. After 20 minutes or so while patient was walking back to his car, he had a little bit of a funny taste which tasted like metal. It was funky. It lasted 30 seconds and went away. Outcome of event was recovered on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387627
Sex: F
Age:
State:

Vax Date: 01/27/2021
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: cold feeling in her arms; after the second dose it has become more painful; after the second dose it has become more painful; This is a spontaneous report from a contactable consumer (patient herself). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, on 27Jan2021, as 2nd dose, single dose, for COVID -19 immunisation. The patient's medical history included pain in her arm before receiving the vaccine. The patient's concomitant medications were not reported. On unspecified date in 2021, it was reported that since the last two weeks or 10 days or so, the patient experienced a cold feeling in her arms almost everyday once a day in both arms. She stated that before receiving the vaccine she would get pain in her arms but after the second dose it has become more painful and then went away. The patient queried if that was going to be a long-term effect of the vaccine. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1387628
Sex: F
Age:
State: TX

Vax Date: 03/13/2021
Onset Date: 03/13/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: feet restless and jittery; feet restless and jittery; Increased high anxiety, difficulty calming down; legs jittery/feet jittery; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration administered in left arm on 13Mar2021 at 14:30 (at 72 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included diabetic, hypothyroid, high blood pressure, gastroesophageal reflux disease (GERD), chronic kidney disease, and restless legs; all from unspecified date. Concomitant medications included dioxybenzone/padimate o (SUNGARD) 12.5 mg x2/day and glimepiride 2 mg x2/day, both from unspecified date for unspecified indication. It was unknown if the patent had COVID prior to vaccination. The patient was tested for COVID post vaccination (results unknown). The patient increased high anxiety, legs jittery, feet restless and jittery. The patient had difficulty calming down. All events were non-serious on 13Mar2021 at 17:00. The patient took muscle relaxant, tizanidine 4 mg, but had very little help. No treatment received for other events. Outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch no cannot be obtained.

Other Meds: SUNGARD; GLIMEPIRIDE

Current Illness:

ID: 1387629
Sex: F
Age:
State: NY

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: body aches; headaches; fever reaching as high as 102.2; Severe nausea; This is a spontaneous report from a contactable nurse (patient). A 26-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via intramuscular route, administered in left arm on 16Jan2021 (at 26 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included seasonal allergies and asthma both from unspecified date. Concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (Lot number: EJ16851) via intramuscular route, administered in left arm on 26Dec2020 at 16:45 (at 26 years old) as single dose for COVID-19 immunization. The patient did not have COVID prior to vaccination. The patient was tested for COVID post vaccination. Nasal swab for COVID was negative. On 17Jan2021 at 02:00, approximately 12-16 hours after the second dose, the patient experienced body aches, headaches, fever reaching as high as 102.2 lasting for 3 days, and severe nausea for 6 days; all non-serious. No treatment received for the events. Outcome of the events was recovered on unspecified date in Jan2021. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness:

ID: 1387630
Sex: F
Age:
State: OH

Vax Date: 03/13/2021
Onset Date: 03/13/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Fatigue; confusion; injection site pain (moderate to severe, mild when treated with tylenol, ice, and heat); increased cardiac PVCs; Upper abdominal cramping; This is a spontaneous report from a contactable consumer (patient). A 23-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6202) via an unspecified route of administration, administered in left arm on 13Mar2021 at 16:00 (at 23 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included Ehlers-Danlos Syndrome-Hypermobility type, fibromyalgia, and severe obesity; all from unspecified date. Known allergies: kiwi, penicillins, and sulfa. The patient previously took cefdinir (OMNICEF), esomeprazole sodium (NEXIUM), and levaquin on unspecified date and experienced allergies. Concomitant medications included sertraline hydrochloride (ZOLOFT), lamotrigine (LAMICTAL), dexlansoprazole (DEXILANT), tethinylestradiol/norethisterone (BALZIVA), norethisterone (CAMILA), and "zerte" (as reported); all from unspecified date for unspecified indication. The patient did not have COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient experienced fatigue, confusion, injection site pain (moderate to severe, mild when treated with tylenol, ice, and heat), increased cardiac PVCs, and upper abdominal cramping; all non-serious on 13Mar2021 at 17:00. No treatment received for the other events. Outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: ZOLOFT; LAMICTAL; DEXILANT; BALZIVA; CAMILA

Current Illness:

ID: 1387631
Sex: F
Age:
State: MI

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Dizziness; Weakness; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6202, Expiry Date: unknown) via an unspecified route of administration administered in upper left arm on 23Feb2021 11:00 (at the age of 75-years) as single dose for covid-19 immunization. The patient medical history included ongoing chronic obstructive pulmonary disease she was diagnosed years ago and she was just now receiving since Jun2020 oxygen at night, ongoing cardiac disorder states it was years ago. There was no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient previously received the first dose of bnt162b2 (Lot Number: EM9810) via an unspecified route of administration administered in upper left arm on 02Feb2021 11:00 (at the age of 75-year-old) as single dose for COVID-19 immunization. Patient stated that she had no side effects with the first shot. On 23Feb2021 13:30 after the second dose of vaccination, the patient experienced dizziness and weakness started after that on same day for 24hours. Patient stated the dizziness hit her first and then the weakness came after but started that same day. Patient not sure if she should even report the weakness as when you're dizzy you usually feel week. Patient clarified that the weakness and dizziness stopped on 24Feb2021. Patient stated she had the vaccine card and it said COVID 19 PFIZER BIONTECH. Patient stated she did not see a dose listed for either shot. There was no any relevant tests performed. AE's dose not resulted in physician office and emergency room visit. As for treatment she sat down, pretty much moved from chair to chair and couldn't do much of anything. Outcome of events was recovered on 24Feb2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: COPD (she was diagnosed years ago and she is just now receiving since Jun2020 oxygen at night); Heart disorder (states it was years ago.)

ID: 1387632
Sex: F
Age:
State: VA

Vax Date: 03/08/2021
Onset Date: 03/01/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: red rash on my inner thighs; pain in the injection site; couldn't go back to sleep; chills; my throat hurt; tired; muscle pain; my arm hurt; pain in my shoulder is much improved though; This is a spontaneous report from a contactable consumer (patient). A 72-year-old non pregnant female patient received second dose of BNT162B2 (Solution for injection, lot number: EN6199 expiry date: unknown) via an unspecified route of administration in Right arm on 08Mar2021 10:45 as a single dose for Covid-19 immunization. Medical history included high blood pressure and cholesterol, she had diverticulosis, but it was not active at the time of this report. She did not have any known allergies. Concomitant medications in two weeks included Amlodepine, Rosuvastatin and unspecified prescription medicine for high blood pressure and cholesterol. The patient previously received first dose of BNT162B2 (Solution for injection, lot number: EN6201 expiry date: unknown) via an unspecified route of administration in Left arm on 15Feb2021 14:00, as a single dose for Covid-19 immunization. The patient did not receive any other vac-cine in four weeks of suspect vaccine. It was stated that the first shot caused soreness in her arm where the injection was made, which went away after about three days. After about 10 days, she developed a rash on both inner thighs. It cleared up in about three days. The patient also had a rash on the left side of face about the same time. She received second shot two days prior to this report, on 08Mar2021, the day of vaccination, the patient experienced that her arm hurt, and she woke up about 4:30 am and could not go back to sleep because it hurt so. She had chills that day, her throat hurt, she felt so tired, and had muscle pain. On 10Mar2021 the day of this report, two days after the shot, she had the red rash on inner thighs again, but the other symptoms (except for the pain in the injection site) were gone. The pain in her shoulder was much improved though. She did take one acetaminophen a day prior to this report in afternoon. The patient did not have Covid prior to vaccination and was not tested for it post vaccination. The outcome of the events of was resolving. No follow-up attempts were Possible. No further information was expected.

Other Meds: AMLODIPINE; ROSUVASTATIN

Current Illness:

ID: 1387633
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Swollen lymph nodes; This is a spontaneous report from a contactable Consumer or other non-health professional (reported for daughter). A female patient of unknown age (Age:18; unit: Unknown) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number and expiration date: not reported) via an unknown route of administration on an unknown date in 2021 (reported as a week ago) as single dose for COVID-19 immunization. Patient received first dose of BNT162B2 (solution for injection, Batch/Lot number and expiration date: not reported) via an unknown route of administration on an unknown date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, the caller was calling regarding the covid vaccine. The caller's daughter was 18, the whole family got vaccinated, when the caller's daughter got the first shot her armpit lymph nodes were swollen and then it went away on an unknown date. Now the caller's daughter noticed that, underneath her jaw her lymph nodes were swollen. The caller made an appointment to go to the doctor a little bit later. The caller wants to know this could be a side effect even though she took the second vaccine a week ago. The first time the lymph nodes were inflamed under the caller's daughter's arms, but the caller's daughter just noticed this swelling under her neck/jaw area, so the reporter was unsure how long it has been like this. The outcome of the event was unknown. No follow-up attempts were possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387634
Sex: F
Age:
State:

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: blood shot spot in her eye; This is spontaneous report from a contactable consumer (Patient). This 65-year-old female consumer (patient) reported that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, 0.3mL, Formulation: Solution for injection, Batch/Lot number: EN6198) via an unspecified route of administration into the right arm on 09Mar2021 09:30 (at the age of 65-year-old) as single dose for COVID-19 immunization. The patient medical history included high blood pressure. Concomitant medication included unspecified high blood pressure medicine, vitamins. On 09Mar2021, the patient reported of blood shot spot in her eye which worsened. The patient got her Pfizer Covid vaccine, she got done with her first shot. Yesterday(09Mar2021) the patient came home and nothing was wrong then at 6:00 in the evening her right eye, initially stated like where she got the shot at, it had blood shot in it, she put some eye drops in it for the redness of the eye. She clarified she received the vaccine on the right side. She wanted to know what she needs to do about her eye, should she go to the emergency room or see an eye doctor. Patient height may be a little shorter than 5'2." No investigation assessment. Outcome for the event was not resolved. No follow up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1387635
Sex: F
Age:
State: CA

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: She was having female health issues/yeast infection; This is a spontaneous report from a contactable consumer or other non-HCP. A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6201), via an unspecified route of administration on 25Feb2021 as single dose (at the age of 65-year-old) for covid-19 immunization. Medical history included thyroid disorder included Thyroid medication. Concomitant medication(s) included budesonide, formoterol fumarate (SYMBICORT). On an unspecified date the patient experienced she was having female health issues/yeast infection. Therapeutic measures were taken as a result of she was having female health issues/yeast infection. The outcome of event was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: SYMBICORT

Current Illness:

ID: 1387636
Sex: U
Age:
State: LA

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: very dizzied; headache; This is a spontaneous report from a contactable consumer (Patient, self-reported). A 72-years-old patient of an unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 16Jan2021 11:30 as first dose, single dose for COVID-19 immunization. Medical history included Cholesterol, blood Irregular heartbeat and acid reflux (all ongoing). Concomitant medications included ezetimibe (ZETIA) taking for Cholesterol since 5 years and ongoing, amlodipine besilate (NORVAS) taking for blood pressure since 5 years and ongoing; omeprazole (PROTONIX [OMEPRAZOLE]) taking 2 twice a day for acid reflux since 8 years and ongoing and metoprolol succinate (TOPROL XL) taking 2 twice a day for Irregular heartbeat since 5 years and ongoing. On 16Jan2021, the patient experienced very dizzied and headache. Outcome of the events was unknown (stop in 30 minutes, as reported). No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ZETIA; NORVAS; PROTONIX [OMEPRAZOLE]; TOPROL XL

Current Illness: Acid reflux (esophageal); Blood cholesterol abnormal; Blood pressure abnormal; Heartbeats irregular

ID: 1387637
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: This is a spontaneous report from non-contactable consumer via Pfizer Sales Representative. A 74-year-old male patient received BNT162B2 (Pfizer COVID-19 Vaccine, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as unknown, single dose for COVID-19 immunisation. Medical history included cardiovascular issues and has pacemaker. The patient concomitant medications were not reported. On an unknown date, the patient experienced rapid heart rate and had cardioversion to alleviate. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness: Artificial cardiac pacemaker user

ID: 1387638
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: left arm is completely numb; This is a spontaneous report from a PFIZER-sponsored program. A contactable female consumer reported for herself that on an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Batch/Lot number was not reported, NDC number and expiry date of was not provided) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced left arm is completely numb. It was reported that warm transfer from a PFIZER-sponsored program. patient was calling for an adverse event felt after the first dose of PFIZER COVID vaccine. The left arm was completely numb. She confirmed contact details upon transfer. Patient was calling to find out what she was going to do about it since her arm was not like this before. She went to the Hospital, clarified she went to the ER. She was told by the hospital that PFIZER would be scheduling nerve test to be done. She stated if the vaccine was what caused this to her arm, then she was asking for help from the manufacturer. Stated this was a new year and her deductible was starting out all over. She had to go to ER since her hands was so swelled out. She did not have a left arm to use since it was completely numb. She went to her doctor and the ER and nobody has been able to help her. Her arm was fine before the vaccine and now she has no arm, clarified her arm is completely numb. Describes that it was like when your leg gone to sleep and felt. It's coming out of sleep and it hurts that was what her arm felt like and it has been ten days. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387639
Sex: M
Age:
State: MS

Vax Date: 03/07/2021
Onset Date: 03/08/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: It is like a little sore; Under his arm there is a big swollen knot under his arm; This is a spontaneous report from a contactable consumer. The 46-year-old Male consumer reported for himself. A 46-years-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number may be EN6205, expiry date: unknown) via an unspecified route of administration in Arm Left on 07Mar2021 09:00 as SINGLE DOSE for covid-19 immunization at primary care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history and no concomitant medications were reported. He is a Veteran and got the vaccine on Sunday (07mar2021). On 08Mar2021 at 10:00 patient felt there is a big swollen knot under his arm. He felt like there is pressure on it when he puts his arm down. It's like on top and squeezes it. It is like a little sore. It is not hard. That is why he is thinking it is lymph nodes/glands. He does not think it is a cyst or anything and this occurred with left arm. No relevant test reported. The clinical outcome of the events were recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387640
Sex: U
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: shingles; This is a spontaneous report from a contactable other health care Professional (HCP). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection) via an unspecified route of administration on an unspecified date as unknown, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination patient diagnosed with COVID-19 was unknown. Since the vaccination the patient tested for COVID-19 was unknown. The patient received any vaccines within four weeks prior to the vaccination was unknown. On an unspecified date the developed shingles. The outcome of the event was unknown. No follow up attempts are possible; information about Lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387641
Sex: F
Age:
State: NY

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Fever; Muscle contractions; couldn't sleep; Major headache; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 12Mar2021 at 15:30 (at the age of 47-year-old), as single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 19Feb2021 at 15:15 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, the patient experienced high fever(39C) for more than 24 hours, muscle contractions which were painful, could not sleep and major headaches. The patient did not receive any treatment for the reported adverse event. The clinical outcome of the event high fever(37C), muscle contraction, sleeplessness and major headaches were recovered. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1387642
Sex: M
Age:
State: CT

Vax Date: 03/10/2021
Onset Date: 03/01/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Sore arm at injection site; This is spontaneous report from a non-contactable consumer, the patient. A 60-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch number: Unknown), via an unspecified route of administration and in unspecified anatomical site on 10Mar2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. Patient was not allergic to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date in Mar2021, the patient experienced sore arm at injection site. The patient did not receive treatment for the event. The clinical outcome of the event sore arm at injection site was resolving at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387643
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: made her sick; couldn't sleep; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medication included pregabalin (LYRICA) for fibromyalgia. On an unspecified date, the patient stated that the 2nd vaccine shot made her sick and couldn't sleep. The outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: LYRICA

Current Illness:

ID: 1387644
Sex: F
Age:
State: CA

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: at 25 minutes after injection, left side of my throat felt numb; Red rash developed on right throat andspread to chest and left side of throat; Agitated; Shaky; Hard toswallow; Blood pressure went highover 200; This is a spontaneous report received from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on the right arm on 15Mar2021 at 14:00 (at the age of 59-year-old), as single dose for COVID-19 immunisation. Medical history included hypothyroidism, high blood pressure, kidney cancer. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included lisinopril, levothyroxine, milk thistle. Past drug included penicillin for which patient developed allergy. On 15Mar2021 at 14:25, after 25 minutes of vaccination, the patient's left side of the throat felt numb, then a red rash developed on right throat, spread to chest and then to left side of throat, then patient felt agitated, shaky, was unable to swallow and blood pressure went high over 200. After about 30 minutes events started to reverse. It was unknown whether the patient received treatment for the events. The clinical outcome of events numbness throat, red rash, agitated, shaky feeling, unable to swallow and blood pressure went high was resolved in Mar2021. Information about lot number cannot be obtained. No further information is expected.

Other Meds: MILK THISTLE; Levoxlthyroxine; LISINOPRIL

Current Illness:

ID: 1387645
Sex: U
Age:
State: CO

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Gout flare; This is a spontaneous report from a contactable consumer, the patient. A 62-years-old patient of unknown gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown, Dose number: 1) via an unspecified route of administration in the left arm on 25Feb2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient's medical history and concomitant medications were not reported. On 26Feb2021 at 14:30 (start day after vaccination), the patient had gout flare. The patient was treated for the event gout flare with Indomethacin (INDOCIN). The clinical outcome of the gout flare was unknown. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1387646
Sex: M
Age:
State: WI

Vax Date: 02/25/2021
Onset Date: 03/03/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Ringing in ears; This is a spontaneous report received from a contactable consumer. A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) as a single dose via unspecified route in the right arm on 25Feb2021 at 10:00 for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient had no allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that the patient did not receive any other vaccines or medications within 4 weeks prior to the COVID-19 vaccination. On 03Mar2021 at 08:00, the patient experienced ringing in ears. No treatment was received for the event. The clinical outcome of ringing in ears was not resolved at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. Amendment: This follow-up report is being submitted to amend previously reported information: Patient's detail contact information was added per reporter since reporting for self. 2. Patient's "Age at Vaccination" captured as 65 years per vaccination date=25Feb2021 and DoB. 3. "Relevant Med History" captured as "None" per source reported "other medical history: None" and also no allergy and "if covid prior vaccination: No". 4. "Unknown" removed from Lot# field for suspect vaccine. 5. For event: "Treatment Received?" captured as "No" per source reported "if treatment ae: No". 6. Final sentence "Information about Lot number cannot be obtained. No further information is expected." updated as "No follow-up attempts are needed; information about lot/batch number cannot be obtained." 7. "Concomitant Therapy" captured as None per source "if_other_vaccine_in_fourweeks: No" and "other_medications_in_twoweeks: No". 8. Initial information need be reviewed: covid_vaccine_details: product=COVID 19, brand=Pfizer, lot_unknown=True, lot_unknown_reason=Other, lot_unknown_reason_other=Don't know , administration_date=25Feb2021, administration_time=10:00 AM, vaccine_location=Right arm, dose_number=1, other_vaccine_same_date_details: other_vaccine_same_date_vaccine_date=25Feb2021, facility_type_vaccine: Other, if_other_vaccine_in_four weeks: No, other_medications_in_two weeks: No, other_medical_history: None

Other Meds:

Current Illness:

ID: 1387647
Sex: F
Age:
State:

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: migraine; This is a spontaneous report from a non-contactable consumer reporting for his wife. A female patient of an unspecified age received BNT162B2 (Lot number was not reported), via an unspecified route of administration on 11Mar2021 as 2nd dose, single for COVID-19 immunization; eletriptan hbr (RELPAX, strength: 40 mg, Lot number was not reported), via an unspecified route of administration from an unspecified date and ongoing, at 40 mg for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient started experiencing migraine in the morning of 12Mar2021 after taking the final dose of the Covid-19 vaccine on 11Mar2021. The patient felt the event was related to use of RELPAX (eletriptan HBr) 40 mg. As of 12Mar2021, the event subsided, and use of eletriptan HBr 40 mg continues. The action taken in response to the event for eletriptan hbr was dose not changed. The patient recovered from the event on 12Mar2021. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds: Relpax

Current Illness:

ID: 1387648
Sex: F
Age:
State: CT

Vax Date: 03/12/2021
Onset Date: 03/14/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Lymph Node swelling under armpit - same arm as injection, this began 2 days after the injection and has persisted.; This is a spontaneous report from a contactable non-health care professional. A 59-year-old non-pregnant female patient received first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration, on left arm on 12Mar2021 at 11:00 (at the age of 59-years-old) as single dose for COVID-19 immunisation. Medical history included hyper tension, occasional migraines, depression. Concomitant medications included MD-cholesterol( MANUFACTURER UNKNOWN) ,curcumin( MANUFACTURER UNKNOWN), fluoxetine(PROZAC) , tekturna( MANUFACTURER UNKNOWN), amlodipine besylate( MANUFACTURER UNKNOWN), baby aspirin (MANUFACTURER UNKNOWN), losartan-hctz 100 ( MANUFACTURER UNKNOWN), magnesium ( MANUFACTURER UNKNOWN)and tylenol (MANUFACTURER UNKNOWN) . The patient had not received any other vaccines within four weeks prior to the COVID vaccine and was not been diagnosed with COVID-19. Patient experienced Lymph Node swelling under armpit - same arm as injection on 14Mar2021 at 13:00. The patient did not receive any treatment for reported events. The clinical outcome of event Lymph Node swelling was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: BABY ASPIRIN; Losartan-HCTZ; AMLODIPINE BESYLATE; TYLENOL; TEKTURNA; MAGNESIUM; CURCUMIN; PROZAC

Current Illness:

ID: 1387649
Sex: M
Age:
State: PA

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 47-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number- UNKNOWN) via an unspecified route of administration in left arm on 16Mar2021 at 09:30 (at an age of 47-years-old) as single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number- UNKNOWN) via an unspecified route of administration on 23Feb2021 at 09:30 (at an age of 47-years-old) as single dose for COVID-19 immunisation. On 17Mar2021, the patient experienced fatigue and headache. The patient didn't receive treatment for the events. The clinical outcome of fatigue and headache were recovered on an unknown date in Mar2021. Information about lot/batch number cannot be obtained. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1387650
Sex: F
Age:
State: AZ

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Severe gastrointestinal upset. Vomiting and diarrhea; Severe gastrointestinal upset. Vomiting and diarrhea; Severe gastrointestinal upset. Vomiting and diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6207), via an unspecified route of administration in the left arm on 17Mar2021 at 13:30 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. The patients medical history included anxiety and depression. The patient had allergies to medications menthol (MANUFACTURER UNKNOWN) and doxycycline (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included PROZAC and PRILOSEC for unknown indications within 2 weeks of vaccination from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 28Jan2021, the patient experienced severe gastrointestinal upset, vomiting and diarrhoea. The clinical outcome of the events severe gastrointestinal upset, vomiting and diarrhoea was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC; Prilosec

Current Illness:

ID: 1387651
Sex: F
Age:
State: WI

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Arm soreness at injection site; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 15:00 (at the age of 58-year-old), as single dose for COVID-19 immunisation. The patient medical history included asthma. Concomitant medications included Allegra, vitamin D (MANUFACTURER UNKNOWN), Afrin decongestant nose spray for unspecified indications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 15:15, the patient experienced arm soreness at injection site. The clinical outcome of event arm soreness at injection site was recovering. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ALLEGRA; Afrin decongestant nose spray; Vitamin D

Current Illness:

ID: 1387652
Sex: F
Age:
State: CA

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: upper back pain; neck pain; Thirsty; hungry; Nausea and feeling of vomit; Wrist /Hip/ joint pain; Swollen throat; Left under arm lymph node swollen, swollen lymph node behind ears near jaw and below chin; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) as single dose via an unspecified route of administration on left arm on 11Mar2021 at 18:30 (at the age of 46-years-old) for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was reported that none other medications received by the patient within 2 weeks of vaccination. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to and since vaccination, the patient was not been diagnosed with COVID-19. On 11Mar2021 at 20:30, the patient experienced hungry, nausea and feeling of vomit, neck pain, swollen throat, thirsty, upper back pain, wrist /hip/ joint pain and also reported left under arm lymph node swollen, swollen lymph node behind ears near jaw and below chin. The patient says no fever and it was a week after 1st dose and symptoms still existed and she felt like she was overdosed. The patient visited Doctor or other healthcare professional office/clinic and she reported the same to physician and waiting for response. Therapeutic measures taken was unknown. The clinical outcome of events hungry, nausea and feeling of vomit, neck pain, swollen throat, thirsty, upper back pain, wrist /hip/ joint pain, left under arm lymph node swollen, swollen lymph node behind ears near jaw and below chin were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1387653
Sex: F
Age:
State: GA

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: swollen axillary lymph nodes; tender axillary lymph nodes; sore neck on the side of the injection.; Lots of nausea; This is a spontaneous report received from a contactable other Health care professional. A 35-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in her left arm on 16Mar2021 at 13:15 (at the age of 35-years-old), for covid-19 immunisation. The patients medical history included penicillin allergy. Past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266), via an unspecified route of administration in her left arm on 23Feb2021 at 13:45 for covid-19 immunisation. Concomitant medications were not reported. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient has not tested positive for COVID-19 since having the vaccine. The patient has not diagnosed with COVID-19 prior to vaccination. On 16Mar2021, the patient experienced lots of nausea and on 18Mar2021 the patient experienced swollen and tender axillary lymph nodes and also had sore neck on the side of the injection. The clinical outcome for the events experienced nausea, swollen and tender axillary lymph nodes and sore neck was not recovered. The patient did not receive any treatment for the reported events. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1387654
Sex: F
Age:
State: CA

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: More Tired; More Sad; Lot of Chills; This is a spontaneous report from a non-contactable, other healthcare professional. A 36-years-old female patient received an UNKNOWN dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/Batch Number: UNKNOWN), via an unspecified route of administration at an unspecified site on 06Mar2021 (at the age of 36-years old) for COVID-19 immunisation. The past medical history of the patient included diagnosis with COVID-19 prior to the vaccination. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccine within four weeks before the COVID-19 vaccine and received the birth control patch within two weeks of the vaccination. On 06Mar2021, the patient experienced chills, tiredness, and feeling sad. The patient reported that she was feeling a lot of chills since she received the vaccine, and was more tired, and sad. The clinical outcome of the events, chills, tiredness, and feeling sad was unknown. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Birth Control Patch

Current Illness:

ID: 1387655
Sex: F
Age:
State:

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: feeling crummy; This is a spontaneous report from a contactable other healthcare professional and consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 11Mar2021 (Batch/Lot number was not reported) at the age of 81 years old as 2nd dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that following the injection of the second dose of COVID vaccine on 11Mar2021, the patient was feeling crummy. Unsure if MD was aware. The outcome of the event was unknown. The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1387656
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 03/18/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Vaccine triggered IBS symptoms; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: en6206), via unspecified route of administration in left arm on 18Mar2021 at 9:30 (at the age of 26-year-old at vaccination) as a single dose for COVID-19 immunisation. Medical history included IBS (irritable bowel syndrome). The patient had no allergies to medications, food or other products. Concomitant medications included ADDERAL, CLARITIN, LOESTRIN Fe, PROBIO and VITAMIN D (MANUFACTURER UNKNOWN); all for an unknown indication started since unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. On 18Mar2021 at 11:00, the vaccine triggered irritable bowel syndrome for the patient. The patient experienced diarrhoea an hour post injection and it was following every two hours. No therapeutic measures were taken for the events. The clinical outcome of the event irritable bowel syndrome aggravated was not resolved at the time of this report. No further information is expected. No follow-up is possible.

Other Meds: Vitamin D; Claritin; ADDERALL; LOESTRIN FE; PROBIO

Current Illness:

ID: 1387657
Sex: M
Age:
State: PA

Vax Date: 03/16/2021
Onset Date: 03/18/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: 99 degree fever; This is a spontaneous report from a contactable consumer or other non-health care professional, the patient. A 43-year-old male patient received BNT162B2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, lot number: En6204), Dose: 1 on the left arm via an unspecified route of administration on 16Mar2021 at 12:45 PM (at the age of 43-years-old), as a single dose for COVID-19 immunisation. The patient did not have any known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. On 18Mar2021 at 3:15 PM, the patient experienced 99 degrees fever. As a therapeutic measure took Tylenol at home Prior to vaccination. The clinical outcome of 99-degree fever was recovering at time of reporting. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1387658
Sex: M
Age:
State:

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: developed insomnia.; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (Age: 74, Unit: Unknown) received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 02Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. It was reported that patient received his first Pfizer Covid vaccine on 02Mar2021. Immediately after the vaccine he developed insomnia. For the next 10 days he reported he would get about 1-2 hours of sleep. Patient is scheduled for the second Pfizer Covid vaccine on 30Mar2021 and he was asking if he should receive the second Pfizer Covid vaccine. Patient wanted to know if he should expect the same reaction with the second vaccine and if so how long. If same reaction is expected with second vaccine patient wanted to know what he can take for the Insomnia. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387659
Sex: F
Age:
State: NY

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Chills; headache; fever; This is a spontaneous report received from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in her left arm on 16Mar2021 at 14:00 (at the age of 55-years-old), for covid-19 immunisation. The patients medical history was reporetd as none. Past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in left arm on 23Feb2021 at 14:00 for covid-19 immunisation. The patient has reported no allergies to medications, food or other products. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not received other medications within 2 weeks of vaccination. The patient has not tested positive for COVID-19 since having the vaccine. The patient has not diagnosed with COVID-19 prior to vaccination. On 17Mar2021, the patient experienced chills, headache and fever. The patient did not receive treatment for the reported events. The clinical outcome for the events experienced chills, headache and fever recovered on unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1387660
Sex: F
Age:
State: CA

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: slight dry cough.; allergic reaction within 15 mins; Itchy Hive on forehead; red rash on both hands; one itchy eye; Headache; This is a spontaneous report from a non-contactable Patient. A 73-Years-old-non-pregnant female patient received dose 1 as single of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613,) via an unspecified route of administration into right arm on 17Mar2021 at 13:45 hours (at the age of 73-years-old) for COVID-19 immunisation. Medical history of the patient includes High Blood Pressure from an unknown date. Concomitant medications of the patient include Norvasc 5 mg/day (Manufacturer unknown) for an unknown indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had a severe allergy towards for Shellfish. Prior to vaccination and since the vaccination the patient had not been diagnosed with COVID-19. The patient experienced Allergic reaction within 15 minutes, Itchy Hive on forehead, red rash on both hands, one itchy eye, headache, and slight dry cough 17Mar2021.The patient did not receive any treatment for the adverse events. The patient recovered from all the events Hive, Red rash, Itchy eye, Headache and Dry Cough on an unknown date. No follow-up attempts are possible, no further information is expected

Other Meds: NORVASC

Current Illness:

ID: 1387661
Sex: F
Age:
State: CO

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: chin hot, red, itchy and warm; chin was hot; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old female patient received BNT162B2 (Pfizer BioNTech Covid 19 mRNA Vaccine; lot number: EN6203,) administered in Arm Left for COVID-19 immunisation on 02Mar2021 at 01:45 Pm. The patient medical history included High blood pressure, brain aneurysm, gall bladder removed. The concomitant drug history of the patient was Hydrochlorothiazide (MANUFACTURER UNKNOWN) for an unknown indication. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. On 02Mar2021 at 14:30 Pm she experienced chin hot, red, itchy and warm. The clinical outcome of the event chin hot, red, itchy and warm was not recovered/resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1387662
Sex: M
Age:
State: TN

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Pain; swelling in both hips; stiffness in both hips; lower back pain and stiffness; lower back pain and stiffness; This is a spontaneous report received from a contactable consumer, the patient. A 49-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration, in the left arm on 17Mar2021 at 08:45 (at the age 49-year-old) as a single dose for COVID-19 immunisation. Medical history included coronary artery disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication includes LIPITOR from an unknown start date and for an unknown indication. The facility where the most recent COVID-19 vaccine was administered was at pharmacy. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 18Mar2021 at 16:00, the patient experienced pain, swelling and stiffness in both hips with lower back pain and stiffness. The patient did not receive treatment for adverse events. The clinical outcome of the events pain, swelling in hips, stiffness in hips, lower back pain and back stiffness was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: Lipitor

Current Illness:

ID: 1387663
Sex: F
Age:
State: GA

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: fast heart rate, of approximately 137 bpm, with littlemovement; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in left arm on 04Mar2021 at 15:00 hours (at the age of 55-years) as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809) via an unspecified route of administration in left arm on 09Feb2021 at 15:30 hours as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to Sudafed. Concomitant medications included levothyroxine 112 mg (MANUFACTURER UNKNOWN), Lumigan 0.01 percent (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN). The patient took these medications with 2 weeks of vaccination and exact therapy dates and indication of these medications were not provided. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Mar2021 at 05:00 hours, approximately 12 to 14 hours after the second vaccine was injected, the patient experienced a fast heart rate, of approximately 137 bpm, with little movement. The patient was given an intravenous (IV) and baby aspirin. The clinical outcome of the event increased heart rate was resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; LUMIGAN; multivitamin

Current Illness:

ID: 1387664
Sex: F
Age:
State:

Vax Date: 02/23/2021
Onset Date: 03/15/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Body Aches; Chills; Fatigue; This is a spontaneous report from a contactable consume, the patient. A 29-Year-old adult female patient was received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot no: EL3247) via an unspecified route of administration in right arm on 23Feb2021 at 10:00 hours for COVID-19 immunisation. Patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot no: EL3247) via an unspecified route of administration in right arm on 16Mar2021 at 10:00 hours for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, patient was not diagnosed with COVID-19, Since the vaccination, patient was not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 15Mar2021 at 22:00 hours, the patient experienced body aches, chills and fatigue. No therapeutic measures were taken as a result of events. The clinical outcome of body aches, chills and fatigue were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1387665
Sex: M
Age:
State: LA

Vax Date: 03/02/2021
Onset Date: 03/10/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Developed Shingles. Diagnosed by Primary Care provider; This is a spontaneous report from a contactable consumer, the patient. A 60-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number- UNKNOWN) via an unspecified route of administration in left arm on 02Mar2021 at 14:30 (at an age of 60-years-old) as single dose for COVID-19 vaccination. Medical history included heart disease, unspecified from an unknown start date and unknown if continuing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient didnt have any allergies to medications, food, or other products. The patient didnt receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included AVODART, Statins (MANUFACTURER UNKNOWN), Blood pressure medicine (MANUFACTURER UNKNOWN); all taken for unknown indication from an unknown start date and unknown if ongoing. On 10Mar2021, the patient developed Shingles. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received included famciclovir (MANUFACTURER UNKNOWN) taken for Shingles from an unknown start date. The clinical outcome of Shingles was not recovered. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: AVODART

Current Illness:

ID: 1387666
Sex: M
Age:
State: CA

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: throat itchy and scratchy; hard to breathe; fever; fatigue; arm pain; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown), via an unspecified route of administration in the right arm on 16Mar2021 at 12:00 pm (at the age of 31 years old) as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not have allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 1:15pm the patient developed itchy throat and scratchy, found hard to breathe (difficulty breathing), fever, fatigue and arm pain. The patient did not receive treatment for the events. The clinical outcome of itchy throat, difficulty breathing, fever, fatigue and arm pain was not resolved. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1387667
Sex: F
Age:
State:

Vax Date: 03/02/2021
Onset Date: 03/06/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: fever; nasal/head congestion; This is a spontaneous report from a non-contactable consumer, the patient. A 63-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: Unknown) via an unspecified route of administration in the right arm on 02Mar2021 as a single dose for COVID-19 immunisation. Patients medical history included thyroid. Concomitant medications included levothyroxine 0.125 mcg qd, and baby ASA qd from unspecified date for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination the patient underwent a COVID-19 virus test (spit test) on 08Mar2021, the result found to be negative. The patient experienced fever, nasal/head congestion on 06Mar2021. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events was recovered on 10Mar2021. No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.

Other Meds: Baby ASA; LEVOTHYROXINE

Current Illness:

ID: 1387668
Sex: F
Age:
State: NJ

Vax Date: 03/11/2021
Onset Date: 03/13/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: has an ear infection currently; fluid in the ear; sneezing badly; nose got bloody; This is a spontaneous report received from a contactable other hcp. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Mar2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced an ear infection currently and fluid in the ear. In Mar2021 she was sneezing badly, and her nose got bloody. She wanted to know if she can take stool softener after getting vaccine. She had an ear infection currently/fluid in the ear that was a recurring issue and was happening before she got the first dose of the Pfizer Covid 19 vaccine. She states it was not due to the vaccine. She was using a prescribed topical ear drop however she may possibly have to take oral amoxicillin. The pharmacist told her that it would not be a good idea to take antibiotic two weeks prior or post vaccine administration. Her doctor did not feel it was an issue. She wanted to know if she takes amoxicillin and get the second dose of the vaccine. On 12Mar2021, she was prescribed amoxicillin by her Doctor because her Doctor wanted to take the fluid out in her ears. But a pharmacist told her that she should not take the amoxicillin because she already took the 1st dose. She did not take the amoxicillin because her Doctor told to take that when they see an infection after they take the fluid out. She mentioned as well that last 13Mar2021 she woke up sneezing very bad that her nose got bloody. Escalating this because the caller was sneezing badly after she got the 1st dose. The outcome of events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387669
Sex: F
Age:
State: AR

Vax Date: 12/01/2020
Onset Date: 05/01/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: She is under a lot of stress; She has not felt herself in the last two weeks/feels silly; This is a spontaneous report from a Pfizer sponsored program received from a contactable consumer (patient). A 70-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 70-years-old, at 2nd dose, single dose for COVID-19 immunisation and started to receive tofacitinib citrate (XELJANZ XR) in Dec2020 and ongoing for rheumatoid arthritis; methotrexate sodium on an unspecified date. Medical history included rheumatoid arthritis. Concomitant medications were not reported. The patient had not felt herself in the last two weeks, prior the report, in May2021. She asked if this was common with rheumatoid arthritis or the product. She had been told it could be the weather. She felt silly. She was under a lot of stress and it could be the stress. She asked if there were any reactions from methotrexate sodium, tofacitinib citrate and BNT162b2 combined in the system. The action taken with tofacitinib citrate and methotrexate sodium was unknown. The outcome of the events was unknown. Pfizer is a marketing authorization holder of methotrexate sodium in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of methotrexate sodium has submitted the same report to the regulatory authorities. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387670
Sex: F
Age:
State: MO

Vax Date: 02/01/2021
Onset Date: 03/01/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: 2 big circles where the shot went in. It was kind of red; This is a spontaneous report from a contactable consumer (patient) via Pfizer RxPathways and from a Pfizer sponsored program COVAX US support. A 72-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), on Feb2021 at single dose in arm for covid-19 immunisation; celecoxib (CELEBREX 100 mg), via an unspecified route of administration from an unspecified date to an unspecified date, at 100 mg unknown frequency for an unspecified indication. The patient medical history and concomitant medications were not reported. Previously the patient took celecoxib and experienced chest hurt. On an unspecified date in Mar2021, the patient experienced 2 big circles where the shot went in, around injection site and both circles were a different color; it was kind of red, now it was kind of brown and the outside of it was kind of light pink. The outcome of the event was unknown.No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1387671
Sex: F
Age:
State: NC

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Felt dizzy; lightheaded to some degree continuously since the vaccination, for three weeks; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Feb2021 at 13:30 hours, as a single dose for COVID-19 immunisation. Medical history included root canal, abscess (root abscess), allergy to pollen and synthetic morphine. The patients past medication included synthetic morphine and had reaction itchiness. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Concomitant medications included PREMARIN via vaginal route for an unknown indication from an unknown date. On 26Feb2021 at 12:00 hours, the patient felt dizzy and lightheaded. The dizziness continued for three days. The patient was lightheaded to some degree continuously since the vaccination, for three weeks. The patient took Flonase by herself. No therapeutic measures were taken for the events. The clinical outcome of felt dizzy and lightheaded was recovering at the time of the report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PREMARIN

Current Illness:

ID: 1387672
Sex: F
Age:
State: NY

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: soreness at site of injection; lethargy; Tiredness; This is a spontaneous report received from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Not unknown) via an unspecified route of administration on 17Mar2021 at 09:45 (at an age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included spherocytosis and spleen removed at age of 2. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received one dose of ADVIL on Mar2021 (previous week) within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 11:00, the patient experienced tiredness, lethargy and soreness at site of injection. The patient did not receive treatment for the reported events. The clinical outcome for the tiredness, lethargy and soreness at site of injection was recovering. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Advil

Current Illness:

ID: 1387673
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/10/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: two allergic reactions; This is a spontaneous report from a contactable pharmacist via Pfizer-sponsored program. This is 2nd of two reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EP7534) via an unspecified route of administration on an unspecified date as UNKNOWN, SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the pharmacist reporting that two allergic reactions with two separate patients within 30 minutes of each other, same lot of vaccine, lot #EP7534. The outcome of the event was unknown. No follow up attempts are possible. No further information is expected. Sender's Comments: Linked Report(s) : US-PFIZER INC-2021323765 same reporter and product / different patients

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm